Mizuho Medy Co.,Ltd. (TYO:4595)
1,551.00
+12.00 (0.78%)
May 30, 2025, 3:30 PM JST
Mizuho Medy Revenue
Mizuho Medy had revenue of 2.65B JPY in the quarter ending March 31, 2025, a decrease of -3.39%. This brings the company's revenue in the last twelve months to 11.34B, down -0.04% year-over-year. In the year 2024, Mizuho Medy had annual revenue of 11.43B with 4.00% growth.
Revenue (ttm)
11.34B
Revenue Growth
-0.04%
P/S Ratio
2.61
Revenue / Employee
60.62M
Employees
187
Market Cap
29.54B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 11.43B | 440.00M | 4.00% |
Dec 31, 2023 | 10.99B | -6.59B | -37.50% |
Dec 31, 2022 | 17.58B | 4.44B | 33.83% |
Dec 31, 2021 | 13.14B | 8.93B | 212.41% |
Dec 31, 2020 | 4.21B | -2.22B | -34.57% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,222.12B |
Daiichi Sankyo Company | 1,886.26B |
Takeda Pharmaceutical Company | 4,581.55B |
HOYA Corporation | 869.37B |
Terumo | 1,036.17B |
Otsuka Holdings | 2,393.18B |
Astellas Pharma | 1,912.32B |
Olympus | 997.33B |